Regional genome transcriptional response of adult mouse brain to hypoxia
© Xu et al; licensee BioMed Central Ltd. 2011
Received: 15 January 2010
Accepted: 11 October 2011
Published: 11 October 2011
Since normal brain function depends upon continuous oxygen delivery and short periods of hypoxia can precondition the brain against subsequent ischemia, this study examined the effects of brief hypoxia on the whole genome transcriptional response in adult mouse brain.
Pronounced changes of gene expression occurred after 3 hours of hypoxia (8% O2) and after 1 hour of re-oxygenation in all brain regions. The hypoxia-responsive genes were predominantly up-regulated in hindbrain and predominantly down-regulated in forebrain - possibly to support hindbrain survival functions at the expense of forebrain cognitive functions. The up-regulated genes had a significant role in cell survival and involved both shared and unshared signaling pathways among different brain regions. Up-regulation of transcriptional signaling including hypoxia inducible factor, insulin growth factor (IGF), the vitamin D3 receptor/retinoid X nuclear receptor, and glucocorticoid signaling was common to many brain regions. However, many of the hypoxia-regulated target genes were specific for one or a few brain regions. Cerebellum, for example, had 1241 transcripts regulated by hypoxia only in cerebellum but not in hippocampus; and, 642 (54%) had at least one hepatic nuclear receptor 4A (HNF4A) binding site and 381 had at least two HNF4A binding sites in their promoters. The data point to HNF4A as a major hypoxia-responsive transcription factor in cerebellum in addition to its known role in regulating erythropoietin transcription. The genes unique to hindbrain may play critical roles in survival during hypoxia.
Differences of forebrain and hindbrain hypoxia-responsive genes may relate to suppression of forebrain cognitive functions and activation of hindbrain survival functions, which may coordinately mediate the neuroprotection afforded by hypoxia preconditioning.
Given that brain depends upon rapid and continuous delivery of oxygen to maintain normal function and survival, it may have developed unique molecular responses to hypoxia as compared to other organs and organisms. In spite of the crucial role of oxygen in normal brain function, there have been relatively few studies of brain hypoxia at the whole genome level. Previous studies using early-generation microarrays found changes of expression in whole brain of neonatal rat (34 genes up-regulated, 42 genes down regulated) and in cerebral cortex of adult mice (29 genes up regulated) [1, 2]. Thus, this study was undertaken in part to examine the brain hypoxia response at the whole genome level in vivo.
One of the major goals of this study, however, was to define the regional, whole genome changes of gene expression that could account for the phenomenon of "hypoxia preconditioning" (HP)[3–7]. In the first described brain HP model, exposure of neonatal rats to 3 hours of 8% oxygen almost completely protected against hypoxia-ischemia induced infarction . In adult mouse brain, hypoxia preconditioning 24 to 48 hours in advance can reduce infarct volume up to 64% [6, 8]. Moreover, the protection provided by HP can last 5-8 weeks [9, 10]. Thus, HP may offer an important platform for the discovery of neuroprotective targets. Though extensively studied, the precise mechanisms accounting for HP remain unknown. Since HP requires new RNA and protein synthesis, we set out to study the whole genome transcriptional response to HP in the adult C57BL/6 mouse brain using Affymetrix Expression Arrays (> 39,000 transcripts) [7, 11, 12]. The dynamic gene expression changes were assessed over the following 24 hours after HP- a time by which the brain would be protected against focal ischemia . Moreover, the expression changes were assessed on a region by region basis: the regional differences of the brain regarding its expression response to hypoxia/HP have not been studied systemically. It is known that certain brain regions and cells, such as hippocampal pyramidal neurons, striatal medium spiny neurons and cerebellar Purkinje neurons, are quite vulnerable to hypoxia/ischemia whereas others can be relatively resistant[13, 14]. It is still not clear whether hypoxia/HP responses could have predominantly engaged common or different mechanisms in different regions. One previous study, using a neonatal rat hypoxia-preconditioning model, showed differential molecular responses in neocortex, hippocampus, striatum and thalamus, even though HP produced similar protection in these regions . Thus, our current study further examined the regional response to HP systemically at the genomic level to determine whether there were common as well as region-specific responses to hypoxia (8% O2) in the brain.
Our study examined both time- and region-dependent transcriptional responses induced by HP in the adult mouse brain. Besides hypoxia inducible factor (HIF), various nuclear receptor transcription factors have been found to play important roles in regulating both the region-independent and region-specific gene expression responses to HP. Different brain region exhibited differential but coordinated responses: in the forebrain, down regulation of gene expression was predominant during peak response period while the hindbrain, especially the cerebellum, demonstrated predominant up-regulation responses to HP. Surprisingly, the cerebellum demonstrated the most profound gene expression response among all regions and may play a pivotal role in the protective effect of HP in vivo.
Many hypoxia regulated gene products are in the nucleus
A one-way ANOVA, corrected for multiple comparisons using a False Discovery Rate of 5%, yielded 2,324 transcripts that changed 1.5 fold or more in at least one brain region after HP treatment in adult C57BL/6 mice. Many (~40%) of these 8% O2 hypoxia-regulated genes have unknown functions. For the well annotated hypoxia-regulated transcripts, almost half of the gene products are located in the nucleus (48.2%) (Additional file 1 figure S1A). Of these, many were transcriptional regulators (34%) (Additional file 1 figure S1B).
Hypoxia-inducible transcription factor (HIF)
Time course of gene expression regulation
Region-dependent gene expression changes
As noted above, only 92 of the 2,324 transcripts regulated by hypoxia were regulated in all of the brain regions investigated. Thus, the hypoxia-regulated genes differed between brain regions (Figure 2, venn diagram) as did the total number of regulated genes. The pons and medulla had the fewest number of regulated genes (330 transcripts with a 1.5-fold threshold) and cerebellum had the most (1312 transcripts with a 1.5-fold threshold) (Figure 2). For each region there were up- and down-regulated genes though down regulated genes were more numerous in the forebrain (Figure 2, cortex, hippocampus, striatum, and thalamus) whereas up-regulated genes predominated in the midbrain, medulla/pons, and particularly, cerebellum (Figure 2). However, the total numbers of up- and down-regulated genes in the brain as a whole are fairly comparable to each other at each time point (Figure 1B).
Gene expression changes in the forebrain related to cell survival
There were generally many more down-regulated genes than up-regulated genes in forebrain regions, a finding similar to that reported for ischemic-preconditioning . A given gene was usually either down- or up-regulated during the entire time course with very few exceptions: only 3 out of 503 genes in the cortex, 12 out 647 genes in the hippocampus, and 8 out 704 genes in the striatum showed expression changes in both directions during the 24 hour period. This means that hypoxia-regulated genes can be simply divided into two classes: up-regulated or down-regulated.
Since cerebral cortex, hippocampus and striatum appear to respond similarly to hypoxia in terms of predominance of a decrease of gene expression, we searched for common signaling pathways among them. Using a 1.2-fold threshold, 314 transcripts were found to be regulated in all three regions in the forebrain. A two-way ANOVA analysis (regions and time courses without FDR correction, p<0.05) on these 314 genes further excluded 14 genes which showed region-dependent expression changes among the forebrain regions. This left 300 HP-regulated transcripts that had a consistent temporal pattern of expression changes across cortex, hippocampus and striatum. This was confirmed using an unsupervised cluster analysis: the expression profiles at the same time points from different regions were similar to one another and therefore clustered together compared to those from neighboring time points (Additional file 1 figure S3).
Signaling pathways significantly associated with commonly up-regulated genes in all the forebrain regions after HP.
Glucocorticoid Receptor Signaling
NFKBIA, FKBP5, CDKN1A, TSC22D3, SGK1
Hypoxia signaling (Cardiovascular System)
Axonal Guidance/Ephrin Receptor Signal
Insulin/IGF-1 Receptor Signaling
PPP1R3C, SGK1, CYR61
H3F3B, PPP1R3C, H3F3A
Candidate transcription factor families responsible for the early transcriptional up-regulation events in the forebrain at 1 hr after HP.
Transcription Factor Families
GO function annotation
Preferentially associated with CNS
Nuclear factor kappa B/c-rel
apoptosis, oxidative stress
CP2-erythrocyte Factor related to drosophila Elf1
steroid biosynthetic process
Y-box binding transcription factors
negative regulation of apoptosis, response to cold
CTCF and BORIS gene family transcriptional regulators
GLI zinc finger family
CNS development, negative regulation of cell proliferation, neurogenesis
E-box binding factors
apoptosis, cell cycle arrest, cell proliferation, ER stress response, regulation of glycolysis
AHR-arnt heterodimers and AHR-related factors
apoptosis, cell cycle, nervous system development, response to stress
Activator protein 2
cell-cell signaling, nervous system development
positive regulation of transcription
Gut-enriched Krueppel like binding factor
mesodermal cell fate determination, negative regulation of cell proliferation
Vertebrate homologues of enhancer of split complex
Notch signaling pathway, cell proliferation, circadian clock, negative regulation of neuron differentiation, vasculogenesis
Myeloid zinc finger 1 factors
Hypoxia inducible factor, bHLH/PAS protein family
CNS development, oxygen homeostasis, circadian rhythm, response to temperature stimulus
Glucocorticoid responsive and related elements
cell growth, cell proliferation, glucocorticoid receptor signaling pathway
Since some or many of the changes of gene expression described here may play a role in producing hypoxia-preconditioning and protecting brain against subsequent stroke, we examined the hypothesis that hypoxia may have modulated many of the same genes as were modulated by ischemic stroke. We therefore compared the hypoxia-regulated genes reported here to stroke-regulated genes identified by recent microarray studies with Affymetrix GeneChip®. One study from our group examined the adult Sprague-Dawley rat brain following a permanent middle cerebral artery occlusion procedure (MCAO) with Affymetrix rat U34A array . The other study, conducted by Sarabi et al., surveyed the same C57BL/6J adult mice brain following transient MCAO procedure with the same Affymetrix mouse MU430_2 array used in our current study . In both studies gene expression was assessed in cerebral cortex within 24 hours after the stroke. 575 rat transcripts on the rat U34A array (8,799 transcripts assessed) were regulated at least 1.5 fold in the periinfarction cortex by acute ischemic stroke, which were homologous to 1000 transcripts on our mouse MU430_2 array. Among the 1000 stroke-regulated transcripts, only 12 transcripts were also regulated by hypoxia according to our current study (Additional file 2 table S5). Sarabi et al. identified 265 transcripts that changed expression following stroke , but only 13 of these were also regulated by hypoxia in our current study (Additional file 2 table S5). Therefore, even though hypoxia changed expression of 503 transcripts in the mouse cerebral cortex, less than 5% (24 transcripts) were also regulated by ischemia.
Unique response of the cerebellum to hypoxia compared to hippocampus
Not only did cerebellum exhibit the most expression changes following HP among all brain regions (1312 transcripts in cerebellum vs. 647 transcripts in hippocampus with a 1.5-fold threshold), it had the largest number of up-regulated genes. We therefore explored the uniqueness of hindbrain structure cerebellum's gene expression response to HP in comparison with the forebrain structure hippocampus because they are comparable in many aspects. They each have a particularly vulnerable cell type: pyramidal cells in hippocampus and Purkinje cells in cerebellum; structurally they share similar grey matter and white matter divisions; and both are relatively primitive brain structures that originated from the archipallium.
Hypoxia responsive pathways in the cerebellum
Canonical signaling pathways associated with region-specific up-regulated genes in the cerebellum following HP.
No. of Genes
Hypoxia Signaling in the Cardiovascular System
UBE2V2, BIRC6, JUN, UBE2G2, UBE2R2 (includes EG:54926), HIF1A, EDN1, PTEN, UBE2G1, VHL
ARF6, PIK3CA, CRKL, ITGB5, PXN, FYN, DOCK1, PTK2, RHOU, ITGA6, RHOT1, TSPAN5, RHOJ, BCAR1, BCAR3, PTEN, RHOV, ZYX
PRKCB1, EIF1AY, EIF1, FOXO1, EIF2S2, PIK3CA, PXN, HIF1A, FOXO3, PTK2
Fc gammar Receptor-mediated Phagocytosis in Macrophages and
PRKCB1, ARF6, PRKCD, PXN, FYN, VAMP3, DGKB, DOCK1, PTEN
Protein Ubiquitination Pathway
UBE2V2, PSMC6, FBXW7, UBE2R2 (includes EG:54926), CUL2, PSMA1, VHL, USP7, BIRC6, UBE2G2, TRAF6, USP53, USP2, UBE2G1
PRKCB1, PRKCD, GNG4, PIK3CA, GNB2L1, PTK2, ARAF, RHOU, RHOT1, TRAF6, RHOJ, RHOV, GNA13
ARAF, PRPF4B, PRKCB1, JUN, DYRK1A, CDK7, PRKCD, FOXO1, PIK3CA, PLCD1, TUBA4A, CSNK1A1
Selenoamino Acid Metabolism
MAT2A, GGT7, SEPHS2, MARS2
IGFBP1, JUN, FOXO1, PIK3CA, CTGF, PXN, FOXO3, PTK2
Estrogen Receptor Signaling
TAF11, IGFBP1, CDK7, POLR2D, TAF9, DDX5, TAF5L, PPARGC1A, NCOA2
PRKCB1, IGFBP1, PRKCD, FOXO1, CEBPB, MXD1, NCOA2
NRF2-mediated Oxidative Stress Response
PRKCB1, JUN, PRKCD, HSPB8, SOD1, PIK3CA, HERPUD1, CUL3, DNAJC5, FKBP5, DNAJC11, MAF
Tight Junction Signaling
CTNNA1, EPB41, PPP2CA, CPSF6, JUN, CSTF1, CNKSR3, CSTF3, MYH7B (includes EG:668940), VAPA, PTEN
IL-12 Signaling and Production in Macrophages
JMJD6, PRKCB1, JUN, PRKCD, PIK3CA, TRAF6, CEBPB, MAF
Glucocorticoid Receptor Signaling
TAF11, AGT, CDK7, SMARCD2, PIK3CA, CEBPB, FKBP5, TAF9, TAF5L, NCOA2, JUN, NR3C2, POLR2D, TRAF6, GTF2A2
FOXO1, PIK3CA, CNKSR3, BCAR1, FOXO3, PTEN, PTK2
Hypoxia regulated, cerebellum specific HNF4A target genes
As the whole cerebellum was used in our current study, we sought evidence for the cellular localization of HNF4A using the Allen Mouse Brain Atlas (8-week old male C57BL/6J mice; in situ hybridization of ~20,000 genes; Allen Institute for Brain Science, Seattle, WA, http://mouse.brain-map.org). A picture from this atlas (Figure 5B) shows HNF4A mRNA in most if not all Purkinje cells of the cerebellum and in scattered cells in the granule cell layers (Figure 5B). HNF4A expression is almost absent in the molecular layers and in the deep nuclei of cerebellum (not shown). This restricted expression in a minority of the cells in cerebellum may explain the failure to detect HNF4A mRNA in whole cerebellum using RT-PCR (Mouse Genome Database, The Jackson Laboratory, Bar Harbor, Maine, http://www.informatics.jax.org) or on microarrays  or in our current study. HNF4A mRNA in situ hybridization has yet to be done in hypoxic cerebellum where cellular localization might change considerably.
Since there has not been any study of potential HNF4A target genes specifically in the cerebellum, a promoter site analysis was therefore performed in Genomatix software to identify additional potential target genes of HNF4A. The results show that 54% (642 genes) of the hypoxia-regulated genes seen only in cerebellum have HNF4A binding sites in their promoter regions. A total of 381 of the 642 genes have two or more binding sites for HNF4A. More interestingly, the integrin signaling pathway, which was exclusively up-regulated in cerebellum but not in hippocampus, was the most significant signaling pathway regulated by the 642 potential HNF4A target genes in the cerebellum.
The results demonstrate both time- and region-dependent gene expression responses to hypoxia. Of the 2324 hypoxia-regulated transcripts, most are specifically regulated in just a few brain regions. Some of them are under the control of similar transcription factors across regions like HIF-1α, GR and VDR/RXR, while others are not. A unique finding is that a large number of cerebellum-specific hypoxia responsive genes appear to be uniquely regulated by the HNF4A transcription factor. The finding of more up-regulated than down-regulated genes in cerebellum and other hindbrain structures compared to more down-regulated genes in forebrain, points to possible sacrifice of forebrain cognitive functions for support of life-preserving hindbrain functions during periods of marked hypoxic stress.
Predominant down-regulation of genes over up-regulation in forebrain following hypoxia could conserve energy but compromise specific forebrain functions. However, there are still many up-regulated genes in forebrain following hypoxia, and these are more involved in regulation of cell survival and cell growth than the down-regulated genes. This selective up regulation of cell survival genes, moreover, was a common feature for all the other investigated brain regions. Specific pathways included those for HIF signaling, glucocorticoid signaling, and P53 signaling, PI3K/AKT and ERK/MAPK signaling. Though the degree of hypoxia used in this study does not produce cell death [3, 22, 23], it may produce diffuse single strand DNA breaks that require repair [24, 25]. This may account for the up-regulation of p53, PI3K/AKT and other pathways involved in DNA repair 
Among the hypoxia regulated genes, many are known HIF target genes [5, 27, 28]. Though HIF-1α plays a pivotal role in hypoxia sensing and signal transduction, its role in mediating hypoxia induced preconditioning effect is controversial, with several studies suggesting that HIF-1α might promote ischemic injury [29–32]. Microarray studies with brain specific HIF-1α knock out mouse even show that HIF-1α is dispensable for the hypoxia response. If HIF related responses do not account for hypoxia preconditioning, then there must be other transcription factors and genes. Indeed, over half of the hypoxia regulated genes common to all brain regions lack HIF binding sites in their promoters but have sites for other hypoxia responsive transcription factors.
The glucocorticoid transcription regulation pathways are not commonly thought of as being associated with hypoxia and other types of preconditioning. However, these pathways might be considered since our promoter analyses show that genes with GRE (Glucocorticoid Responsive Elements) in their promoters are over-represented in those induced by one hour of hypoxia(Table 2), which is sufficient to produce hypoxia preconditioning . Glucocorticoids are systemic stress hormones and can activate the glucocorticoid receptor (GR), a transcription factor that acts on GRE promoter elements . Although the role of glucocorticoids in the context of HP has not been addressed, it is known that hypoxia (8% oxygen) increases glucocorticoids in the blood within 30-60 minutes [34–36]. Glucocorticoids can augment the expression of HIF1α-dependent genes via a direct interaction with HIF-1α . Administration of synthetic glucocorticoids can decrease high altitude sickness, i.e. brain edema due to hypoxia . Glucocorticoids applied 20 hours in advance can protect rat neurons from excitotoxin-induced apoptosis through PI3K/Akt-dependent phosphorylation of Cdkn1a . Of note, our data show that hypoxia increased the expression of Cdkn1a (Fig. S2). According to our data, hypoxia induces many other glucocorticoid-inducible genes, including Tsc22d3, Sgk1, and Nfkb1a, as well as a member of the GR complex - FKBP5 (FK506 binding protein 5). Thus, glucocorticoid signaling could produce an alarm response to the hypoxia stress to augment the adaptive genomic response. Whether GR signaling plays a role in preconditioning has yet to be tested.
There is probably not a single pro-survival molecule or one pro-survival signaling pathway that accounts for hypoxia preconditioning. The redundant activation of multiple pro-survival mechanisms has been observed in many models, including hypoxia and ischemic preconditioning models [9, 17, 40]. Cellular protection may occur at many levels - and thus multiple pathways are needed to protect the cells as shown in Table 1.
The hypoxia preconditioning response appears to have little in common with an injury response. For example, very few transcripts were regulated by both hypoxia and ischemic stroke in the cerebral cortex (Additional file 2 table S5). A similar result has been found between an ischemic preconditioning and an ischemic stroke-induced gene expression response . This result indicates that the protective effect induced by hypoxia is not achieved through a simple rehearsal of the ischemia event, but through a reprogramming of the transcriptional response .
Unlike the forebrain, there were many more up-regulated than down-regulated genes in cerebellum and other hindbrain structures including the pons and medulla. This could be due to the fact that brainstem and cerebellum play critical roles in maintaining cardiac and respiratory functions during periods of severe hypoxia and that higher order cognitive functions are shut down to conserve energy stores during hypoxia[41–43]. Indeed, hypoxic mice and other mammals are lethargic and inactive, but have marked increases of respiration, heart rate and autonomic responses during hypoxia. Our findings on the regional differences serve to emphasize that some aspects of "hypoxia preconditioning" in vivo may not be recapitulated by hypoxia or ischemia preconditioning in vitro.
The large number of up-regulated genes in cerebellum following hypoxia could suggest an important central role for cerebellum in the brain's preconditioning response. As noted above, cerebellum may play a role in coordinating respiratory, circulatory and other autonomic responses to hypoxia[41, 42]. Though possible, it is not clear why there would not be similar numbers of up-regulated genes in the pons and medulla where these functions are primarily controlled. An alternative role for cerebellum in hypoxia preconditioning might occur through "central neurogenic neuroprotection," which is produced by stimulation of the cerebellum fastigial nucleus (FN) . Reis and coworkers found that one hour of electrical stimulation of the FN prior to injury protected the rat brain from subsequent focal ischemia 1-3 days later [45, 46]. The time course of this central neurogenic neuroprotection is similar to that of hypoxia preconditioning. The mechanism of neuroprotection is unknown, though FN stimulation pretreatment can decrease inflammation following ischemia and can modify the intrinsic sensitivity of forebrain neurons to apoptotic stimuli [47, 48]. The many up-regulated genes in cerebellum produced by hypoxia imply that the cerebellum was indeed "stimulated." It is tempting to speculate that changes of gene expression in cerebellum during the hypoxia may be responsible, at least in part, for the hypoxia-induced neuroprotective effect through the "central neurogenic protection" mechanism. Indeed, an excitotoxic lesion of FN neurons prior to preconditioning ischemia blocks the neuroprotective effect of ischemic preconditioning against global ischemia in the rat . Even though the cerebellar FN-mediated neuroprotection effect has been well documented, the neuronal circuitry from cerebellum to forebrain responsible for the preconditioning still has not been identified.
Although the cerebellum exhibits a different response to hypoxia compared to the hippocampus, the response in the cerebellum is still mediated to an extent by well-known hypoxia responsive signaling pathways. Besides HIF-1α, a series of nuclear receptor transcription factors appear to have important roles in the cerebellum-specific up regulation response, including GR, NRF2 (NF-E2-related factor 2), VDR/RXR, and estrogen receptor. One of the major findings of this study, however, is that over half of the 1241 hypoxia-regulated genes unique to cerebellum have binding sites in their promoters for HNF4A, another member of the nuclear receptor family.
As a tissue-specific transcription factor, hepatocyte nuclear factor 4A (HNF4A) was originally identified as a key transcription factor responsible for expression of hepatic-specific genes and is involved in tissue-specific cell differentiation and energy metabolism [20, 50]. Mutations in this gene have been associated with monogenic autosomal dominant non-insulin-dependent diabetes mellitus type I, which stresses the important role of HNF4A in energy metabolism . In addition, conditional HNF4A-knockout mice have down-regulation of a series of cell adhesion and junction molecules and severe failure of epithelial transformation , which is consistent with the potential HNF4A target genes regulated in the hypoxic cerebellum.
HNF4A is also known to be involved in the hypoxia response. HNF4A can interact directly with both HIF-1α and HIF-1β and is required for erythropoietin (EPO) transcription during hypoxia through interaction with HNF4A binding element in the EPO enhancer in the liver and kidney . Mutation of the HNF4A binding site in the EPO promoter abolishes hypoxic induction of EPO . According to our data, HNF4A appears to activate transcription for a large number of cerebellum-specific hypoxia responsive genes. Though a role for HNF4A in the hypoxia response in brain has yet to be proven, the current findings suggest that it plays a major role in the transcriptional response to hypoxia in the mammalian cerebellum.
To the best of our knowledge, our data uncovered so far the most complete HP-induced gene expression responses in the adult mouse brain. Our results confirm that HP elicits both time- and region-dependent transcriptional responses that are required for maturation of the delayed protection effect of HP. Both region-independent and region-dependent expression changes were observed. Developmentally closely related regions share more commonality than remotely related regions: roughly, the response in the forebrain regions is distinctive from that in the hindbrain regions. At the same time, from the whole brain view the region-dependent response in vivo appears to be a well coordinated one under limited energy sources, with hindbrain function being well supported somewhat at the expenses of the forebrain function. Nonetheless, selective up-regulation of cell survival related genes appears to be a common feature for all the brain regions including the forebrain. A large proportion of HP-regulated genes themselves are gene expression regulators. The data analysis suggested the complexity of such underlying transcriptional regulation mechanism: both universal transcriptional regulation mechanism, such as HIF and GR, and region-specific transcription factors, such as HNF4A, have been responsible for the region-specific gene expression changes which is related to cell survival. It is likely that a cascade of signaling pathways rather than any single pathway has mediated the HP response and protection mechanism. Our data also revealed novel transcriptional regulation mechanisms that may have been underappreciated in HP neuroprotection mechanism, and indicated the potentially important role of cerebellum and other hindbrain structures in HP. The exact mechanism and function of the region-dependent responses to HP remain to be fully elucidated.
All studies were reviewed and approved by IACUC (Institutional Animal Care and Use) committee of the University of California at Davis. All mice had food and water available ad libitum on a 12 hour light/dark cycle, and were acclimated to the animal room for at least one week before the experiment.
Hypoxia and Tissue Samples
C57BL/6 male mice, ages 8-9 weeks, were exposed to 8% O2 and 92% N2 for 3 hours in hypoxia chambers (BioSpherix, NY, USA) and then returned to room air in their home cages for 24 hours. Sham-treated control mice were also placed in the same chambers but with room air for 3h, and then returned to their home cages for 24h. During the experiments mouse brains were removed and dissected in a cold room (4°C) at the following time points: immediately after 1 hr of hypoxia (H1), immediately after 3 hr of hypoxia (H3), and after 1 (R1), 3 (R3), 6 (R6), 12 (R12), and 24 (R24) hours of re-oxygenation (R). Total RNA was purified from the following brain regions: cerebral cortex, hippocampus, striatum, thalamus, midbrain, cerebellum and pons/medulla. Three mice were studied for each hypoxia time point and sham condition, for a total of 24 mice studied and 168 samples (microarrays).
RNA and microarray
Brain samples were homogenized in 1 ml of TRIZOL Reagent (Invitrogen Corporation, Carlsbad, California). RNA purification was carried out according to the manufacturer's recommendations (Protocol 18057N, Invitrogen Corporation, Carlsbad, CA). The RNA pellet was cleaned using a RNAeasy mini kit (Qiagen, Valencia, CA). RNA purity and integrity were assessed using a Nanodrop spectrophotometer (NanoDrop Technologies, Wilmington, DE) and an Agilent Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA). Samples (5 μg of total RNA) were processed on whole genome "GeneChip® Mouse Expression 430 2.0" arrays according to the Affymetrix technical manual (Affymetrix GeneChip® Expression Analysis Manual 701023, Rev. 4, Affymetrix). Samples had to have an A260/A280 absorbance ratio greater than 1.9 and a 28S/18S rRNA ratio greater than 1.5. The raw data are available through NCBI Gene Expression Omnibus (GEO) with series accession number [GEO: GSE19709].
Microarray Data Analysis
Raw signals were transformed into .CEL files in GCOS software (Affymetrix, Santa Clara, CA). Probe data were generated using the Robust Multi-chip Average with GC-content Background Correction (GCRMA, http://www.bioconductor.org) in Genespring 7 software (Silicon Genetics, Redwood City, CA). This involves background correction, quantile normalization, and summarization of the probe-set values into gene-level expression measurements. The expression data for each brain region of hypoxia treated mice were then normalized to the averaged values for each brain region from the sham treated mice. Differentially regulated genes were determined using a one-way ANOVA analysis and a Benjamini Hochberg False Discovery Rate (FDR) (<0.05) method for multiple comparison corrections , followed by a Student's post hoc test.
We performed a separate analysis that was designed to minimize the number of false negative genes. Those genes whose expression changed little under the different experimental conditions were filtered out. Specifically, only those genes whose expression changed at least 1.3-fold from the baseline value in at least two of the hypoxia-treated samples were selected for downstream analysis. This filter helped maximize the number of genes. This approach removed approximately 60% of probe sets prior to further analysis. The remaining genes were then subjected to a one-way ANOVA analysis. The resulting gene lists not only contained a significant number of genes that overlapped with the one generated by the aforementioned analysis with no pre-filtering, but it also contained a significant number of genes missed in the initial analysis without the pre-filtering step. These additional positive genes were then combined with the genes derived from the initial analysis without pre-filtering. Less stringent 1.2 fold change gene lists were used for functional analyses and more stringent 1.5-fold change gene lists were used to analyze transcription factor binding sites.
For example, in the cerebral cortex, the analysis of HP samples using pre-filtering indicated that the expression of 831 genes changed during the time course; this set of genes included 94.4% of the 531 genes generated by the same analysis without pre-filtering. The additional 339 genes in the pre-filtering analysis were added to the initial 531 genes, resulting in the final list of 860 genes. However, if a 1.5 fold change cut off was used, a total of 503 genes were identified as HP regulated genes in the cerebral cortex.
Genes that met statistical criteria were analyzed using Ingenuity Pathways Analysis (IPA 6.5, Ingenuity® Systems, http://www.ingenuity.com) to explore molecular functions, signaling pathways and interaction networks. These analyses identified the most statistically significant biological functions or canonical pathways in the data set. Fischer's exact test was used to calculate a p-value describing the probability that a given biological function or canonical pathway was assigned to that data set due to chance alone. An interaction network is a graphical representation of the molecular relationships between genes and gene products. Gene products are represented as nodes, and the biological relationship between two nodes is represented as a line that is supported by at least one reference from the literature.
The in situ hybridization data for HNF4A mRNA expression in cerebellum were obtained from the Allen Brain Atlas, a genome-wide image database of gene expression in the brain of 8 week old C57BL/6J mice (http://mouse.brain-map.org). Non-radioactive digoxigenin-labeled HNF4A riboprobes were synthesized and hybridized to HNF4A mRNA in brain tissue sections. Detailed methods can be found in the reference for the Allen Brain Atlas .
Promoter Prediction and Analysis
Transcription factor binding site (TFBS) analysis of the promoter sequences was carried out in GEMS Software (Genomatix software, www.genomatix.de). GEMS provides genome annotation, promoter sequence retrieval, a search engine for transcription factor binding sites, and a transcription factor knowledge base. Promoter sequences were extracted from 500 bp upstream and 100 bp downstream of the transcription start site of genes of interest. Although the exact length of a promoter can only be defined experimentally, a commonly accepted definition of proximal promoter region for transcription factor binding is typically 250-500 bp located directly upstream of the site of initiation of transcription in eukaryotes . It is a common practice for an initial in silico analysis to refrain from extending the length beyond the proximal promoter region. This will help to minimize false positive findings for computation prediction. Genomatix develops optimized algorithm for promoter modeling and predicting based on the region between 500 bp upstream and 100 bp downstream of the transcription start site. MatInspector within GEMS was used to scan transcription factor matrix matches in input sequences based on position weight matrices. The weight matrix for a specific transcription factor binding site reflects the differences in the degree of conservation of a specific nucleotide at a specific position. In order to reduce false positives, the resulting matrix similarity score for a transcription factor was compared to the optimized threshold value which is individualized for individual transcription factor binding site matrix . A p value was then determined as the probability to obtain an equal or greater number of sequences with a match in a randomly drawn sequence set of the same size as the input sequence set. The computational methods used in Genomatix have been successfully applied to identify proven functional transcription factor binding sites [59, 60].
Additional data files
cyclin-dependent kinase inhibitor 1A
FK506 binding protein 5
cerebellar fastigial nucleus
Glucocorticoid Responsive Elements
Hypoxia-inducible transcription factor
hepatic nuclear receptor 4A
Insulin-like growth factor
Krueppel-like factor 4
nuclear factor of kappa light polypeptide gene enhancer in B-cells
NF-E2-related factor 2. PI3K/AKT: Phosphatidylinositol-3-kinase/Protein kinase B
serum/glucocorticoid regulated kinase 1(Previous name: serum/glucocorticoid regulated kinase)
TSC22 domain family, member 3(Previous name: Glucocorticoid-induced leucine zipper protein)
Vitamin D Receptor/Retinoic Acid X Receptor
This work was supported by NS42774, NS43252, MH67039, NS44283, NS28167 and NS0546452. We thank Ryan Davis and Stephenie Liu in the UCD M.I.N.D. Institute Genomics Facility for their work on the microarrays. We are grateful to Drs. Bruce Lyeth, Robert Berman, Philip Schwartzkroin and Jeffrey Gregg for their help and constructive feedback regarding these studies. We also thank Dr. Arezou Sarabi for communicating details of their published work (Sarabi et al., 2008).
- Bernaudin M, Tang Y, Reilly M, Petit E, Sharp FR: Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem. 2002, 277 (42): 39728-39738. 10.1074/jbc.M204619200.PubMedView ArticleGoogle Scholar
- Tang Y, Pacary E, Freret T, Divoux D, Petit E, Schumann-Bard P, Bernaudin M: Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: Identification of potential neuroprotective candidates for stroke. Neurobiology of Disease. 2006, 21 (1): 18-28. 10.1016/j.nbd.2005.06.002.PubMedView ArticleGoogle Scholar
- Gidday JM, Fitzgibbons JC, Shah AR, Park TS: Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett. 1994, 168 (1-2): 221-224. 10.1016/0304-3940(94)90455-3.PubMedView ArticleGoogle Scholar
- Sharp FR, Ran R, Lu A, Tang Y, Strauss KI, Glass T, Ardizzone T, Bernaudin M: Hypoxic preconditioning protects against ischemic brain injury. NeuroRx. 2004, 1 (1): 26-35. 10.1602/neurorx.1.1.26.PubMed CentralPubMedView ArticleGoogle Scholar
- Ran R, Xu H, Lu A, Bernaudin M, Sharp FR: Hypoxia preconditioning in the brain. Dev Neurosci. 2005, 27 (2-4): 87-92. 10.1159/000085979.PubMedView ArticleGoogle Scholar
- Miller BA, Perez RS, Shah AR, Gonzales ER, Park TS, Gidday JM: Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport. 2001, 12 (8): 1663-1669. 10.1097/00001756-200106130-00030.PubMedView ArticleGoogle Scholar
- Gidday JM: Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci. 2006, 7 (6): 437-448.PubMedView ArticleGoogle Scholar
- Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P: Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab. 2002, 22 (4): 393-403.PubMedView ArticleGoogle Scholar
- Gustavsson M, Wilson MA, Mallard C, Rousset C, Johnston MV, Hagberg H: Global gene expression in the developing rat brain after hypoxic preconditioning: involvement of apoptotic mechanisms?. Pediatr Res. 2007, 61 (4): 444-450. 10.1203/pdr.0b013e3180332be4.PubMedView ArticleGoogle Scholar
- Jones NM, Kardashyan L, Callaway JK, Lee EM, Beart PM: Long-term functional and protective actions of preconditioning with hypoxia, cobalt chloride, and desferrioxamine against hypoxic-ischemic injury in neonatal rats. Pediatr Res. 2008, 63 (6): 620-624. 10.1203/PDR.0b013e31816d9117.PubMedView ArticleGoogle Scholar
- Gage AT, Stanton PK: Hypoxia triggers neuroprotective alterations in hippocampal gene expression via a heme-containing sensor. Brain Res. 1996, 719 (1-2): 172--178. 10.1016/0006-8993(96)00092-3.PubMedView ArticleGoogle Scholar
- Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB: Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci. 2002, 22 (15): 6401-6407.PubMedGoogle Scholar
- Pulsinelli WA, Brierley JB, Plum F: Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol. 1982, 11 (5): 491-498. 10.1002/ana.410110509.PubMedView ArticleGoogle Scholar
- Cervos-Navarro J, Diemer NH: Selective vulnerability in brain hypoxia. Crit Rev Neurobiol. 1991, 6 (3): 149-182.PubMedGoogle Scholar
- Cimarosti H, Jones NM, O'Shea RD, Pow DV, Salbego C, Beart PM: Hypoxic preconditioning in neonatal rat brain involves regulation of excitatory amino acid transporter 2 and estrogen receptor alpha. Neurosci Lett. 2005, 385 (1): 52-57. 10.1016/j.neulet.2005.05.006.PubMedView ArticleGoogle Scholar
- Wenger RH, Stiehl DP, Camenisch G: Integration of oxygen signaling at the consensus HRE. Sci STKE. 2005, 2005 (306): re12.-PubMedGoogle Scholar
- Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, et al: Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet. 2003, 362 (9389): 1028-1037. 10.1016/S0140-6736(03)14412-1.PubMedView ArticleGoogle Scholar
- Lu A, Tang Y, Ran R, Clark JF, Aronow BJ, Sharp FR: Genomics of the periinfarction cortex after focal cerebral ischemia. J Cereb Blood Flow Metab. 2003, 23 (7): 786-810.PubMedView ArticleGoogle Scholar
- Sarabi AS, Shen H, Wang Y, Hoffer BJ, Backman CM: Gene expression patterns in mouse cortical penumbra after focal ischemic brain injury and reperfusion. J Neurosci Res. 2008, 86 (13): 2912-2924. 10.1002/jnr.21734.PubMedView ArticleGoogle Scholar
- Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, et al: Control of pancreas and liver gene expression by HNF transcription factors. Science. 2004, 303 (5662): 1378-1381. 10.1126/science.1089769.PubMed CentralPubMedView ArticleGoogle Scholar
- Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, et al: A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA. 2004, 101 (16): 6062-6067. 10.1073/pnas.0400782101.PubMed CentralPubMedView ArticleGoogle Scholar
- Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR: Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol. 2000, 48 (3): 285-296. 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO;2-8.PubMedView ArticleGoogle Scholar
- Prass K, Scharff A, Ruscher K, Lowl D, Muselmann C, Victorov I, Kapinya K, Dirnagl U, Meisel A: Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke. 2003, 34 (8): 1981-1986. 10.1161/01.STR.0000080381.76409.B2.PubMedView ArticleGoogle Scholar
- Englander EW, Greeley GH, Wang G, Perez-Polo JR, Lee HM: Hypoxia-induced mitochondrial and nuclear DNA damage in the rat brain. J Neurosci Res. 1999, 58 (2): 262-269. 10.1002/(SICI)1097-4547(19991015)58:2<262::AID-JNR6>3.0.CO;2-W.PubMedView ArticleGoogle Scholar
- Risom L, Lundby C, Thomsen JJ, Mikkelsen L, Loft S, Friis G, Moller P: Acute hypoxia and reoxygenation-induced DNA oxidation in human mononuclear blood cells. Mutat Res. 2007, 625 (1-2): 125-133. 10.1016/j.mrfmmm.2007.06.001.PubMedView ArticleGoogle Scholar
- Helton ES, Chen X: p53 modulation of the DNA damage response. J Cell Biochem. 2007, 100 (4): 883-896. 10.1002/jcb.21091.PubMedView ArticleGoogle Scholar
- Jones NM, Bergeron M: Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling. J Neurochem. 2004, 89 (1): 157-167. 10.1111/j.1471-4159.2004.02324.x.PubMedView ArticleGoogle Scholar
- Liu J, Narasimhan P, Yu F, Chan PH: Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke. 2005, 36 (6): 1264-1269. 10.1161/01.STR.0000166180.91042.02.PubMedView ArticleGoogle Scholar
- Greijer AE, van der Wall E: The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol. 2004, 57 (10): 1009-1014. 10.1136/jcp.2003.015032.PubMed CentralPubMedView ArticleGoogle Scholar
- Halterman MW, Miller CC, Federoff HJ: Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci. 1999, 19 (16): 6818-6824.PubMedGoogle Scholar
- Helton R, Cui J, Scheel JR, Ellison JA, Ames C, Gibson C, Blouw B, Ouyang L, Dragatsis I, Zeitlin S, et al: Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci. 2005, 25 (16): 4099-4107. 10.1523/JNEUROSCI.4555-04.2005.PubMedView ArticleGoogle Scholar
- Piret JP, Mottet D, Raes M, Michiels C: Is HIF-1alpha a pro- or an anti-apoptotic protein?. Biochem Pharmacol. 2002, 64 (5-6): 889-892. 10.1016/S0006-2952(02)01155-3.PubMedView ArticleGoogle Scholar
- Datson NA, Morsink MC, Meijer OC, de Kloet ER: Central corticosteroid actions: Search for gene targets. Eur J Pharmacol. 2008, 583 (2-3): 272-289. 10.1016/j.ejphar.2007.11.070.PubMedView ArticleGoogle Scholar
- Furay AR, Bruestle AE, Herman JP: The role of the forebrain glucocorticoid receptor in acute and chronic stress. Endocrinology. 2008, 149 (11): 5482-5490. 10.1210/en.2008-0642.PubMed CentralPubMedView ArticleGoogle Scholar
- Larsen JJ, Hansen JM, Olsen NV, Galbo H, Dela F: The effect of altitude hypoxia on glucose homeostasis in men. J Physiol. 1997, 504 (Pt 1): 241-249.PubMed CentralPubMedView ArticleGoogle Scholar
- Moncloa F, Donayre J, Sobrevilla LA, Guerra-Garcia R: Endocrine studies at high altitude. II. Adrenal cortical function in sea level natives exposed to high altitudes (4300 metersfor two weeks. J Clin Endocrinol Metab. 1965, 25 (12): 1640-1642. 10.1210/jcem-25-12-1640.PubMedView ArticleGoogle Scholar
- Kodama T, Shimizu N, Yoshikawa N, Makino Y, Ouchida R, Okamoto K, Hisada T, Nakamura H, Morimoto C, Tanaka H: Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression. J Biol Chem. 2003, 278 (35): 33384-33391. 10.1074/jbc.M302581200.PubMedView ArticleGoogle Scholar
- Johnson TS, Rock PB, Fulco CS, Trad LA, Spark RF, Maher JT: Prevention of acute mountain sickness by dexamethasone. N Engl J Med. 1984, 310 (11): 683-686. 10.1056/NEJM198403153101103.PubMedView ArticleGoogle Scholar
- Harms C, Albrecht K, Harms U, Seidel K, Hauck L, Baldinger T, Hubner D, Kronenberg G, An J, Ruscher K, et al: Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1/Cip1) as a novel mechanism of neuroprotection by glucocorticoids. J Neurosci. 2007, 27 (17): 4562-4571. 10.1523/JNEUROSCI.5110-06.2007.PubMedView ArticleGoogle Scholar
- Lu XC, Williams AJ, Yao C, Berti R, Hartings JA, Whipple R, Vahey MT, Polavarapu RG, Woller KL, Tortella FC, et al: Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J Neurosci Res. 2004, 77 (6): 843-857. 10.1002/jnr.20218.PubMedView ArticleGoogle Scholar
- Harper RM: The cerebellum and respiratory control. Cerebellum. 2002, 1 (1): 1-2.PubMedView ArticleGoogle Scholar
- Nisimaru N: Cardiovascular modules in the cerebellum. Jpn J Physiol. 2004, 54 (5): 431-448. 10.2170/jjphysiol.54.431.PubMedView ArticleGoogle Scholar
- Pena F, Ramirez JM: Hypoxia-induced changes in neuronal network properties. Mol Neurobiol. 2005, 32 (3): 251-283. 10.1385/MN:32:3:251.PubMedView ArticleGoogle Scholar
- Reis DJ, Golanov EV, Galea E, Feinstein DL: Central neurogenic neuroprotection: central neural systems that protect the brain from hypoxia and ischemia. Ann N Y Acad Sci. 1997, 835: 168-186. 10.1111/j.1749-6632.1997.tb48628.x.PubMedView ArticleGoogle Scholar
- Reis DJ, Berger SB, Underwood MD, Khayata M: Electrical stimulation of cerebellar fastigial nucleus reduces ischemic infarction elicited by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab. 1991, 11 (5): 810-818. 10.1038/jcbfm.1991.139.PubMedView ArticleGoogle Scholar
- Reis DJ, Kobylarz K, Yamamoto S, Golanov EV: Brief electrical stimulation of cerebellar fastigial nucleus conditions long-lasting salvage from focal cerebral ischemia: conditioned central neurogenic neuroprotection. Brain Res. 1998, 780 (1): 161-165. 10.1016/S0006-8993(97)01017-2.PubMedView ArticleGoogle Scholar
- Zhou P, Qian L, Glickstein SB, Golanov EV, Pickel VM, Reis DJ: Electrical stimulation of cerebellar fastigial nucleus protects rat brain, in vitro, from staurosporine-induced apoptosis. J Neurochem. 2001, 79 (2): 328-338.PubMedView ArticleGoogle Scholar
- Galea E, Glickstein SB, Feinstein DL, Golanov EV, Reis DJ: Stimulation of cerebellar fastigial nucleus inhibits interleukin-1beta-induced cerebrovascular inflammation. Am J Physiol. 1998, 275 (6 Pt 2): H2053-2063.PubMedGoogle Scholar
- Rollins S, Chen B, Golanov E: Possible role of cerebellar fastigial nucleus in preconditioned neuroprotection. J Cereb Blood Flow Metab. 2005, 25 (S1): S303-S303.View ArticleGoogle Scholar
- Sladek FM, Zhong WM, Lai E, Darnell JE: Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 1990, 4 (12B): 2353-2365. 10.1101/gad.4.12b.2353.PubMedView ArticleGoogle Scholar
- Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature. 1996, 384 (6608): 458-460. 10.1038/384458a0.PubMedView ArticleGoogle Scholar
- Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM, Duncan SA: Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci USA. 2006, 103 (22): 8419-8424. 10.1073/pnas.0600246103.PubMed CentralPubMedView ArticleGoogle Scholar
- Tsuchiya T, Kominato Y, Ueda M: Human hypoxic signal transduction through a signature motif in hepatocyte nuclear factor 4. J Biochem. 2002, 132 (1): 37-44.PubMedView ArticleGoogle Scholar
- Zhang W, Tsuchiya T, Yasukochi Y: Transitional change in interaction between HIF-1 and HNF-4 in response to hypoxia. J Hum Genet. 1999, 44 (5): 293-299. 10.1007/s100380050163.PubMedView ArticleGoogle Scholar
- Reiner A, Yekutieli D, Benjamini Y: Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics. 2003, 19 (3): 368-375. 10.1093/bioinformatics/btf877.PubMedView ArticleGoogle Scholar
- Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, et al: Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2007, 445 (7124): 168-176. 10.1038/nature05453.PubMedView ArticleGoogle Scholar
- Butler JE, Kadonaga JT: The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev. 2002, 16 (20): 2583-2592. 10.1101/gad.1026202.PubMedView ArticleGoogle Scholar
- Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T: MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics. 2005, 21 (13): 2933-2942. 10.1093/bioinformatics/bti473.PubMedView ArticleGoogle Scholar
- Benos PV, Lapedes AS, Stormo GD: Probabilistic code for DNA recognition by proteins of the EGR family. J Mol Biol. 2002, 323 (4): 701-727. 10.1016/S0022-2836(02)00917-8.PubMedView ArticleGoogle Scholar
- Hoh J, Jin S, Parrado T, Edington J, Levine AJ, Ott J: The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci USA. 2002, 99 (13): 8467-8472. 10.1073/pnas.132268899.PubMed CentralPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.